Literature DB >> 1637802

Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models.

M Bourin1, M Hascoet, B Mansouri, M C Colombel, J Bradwejn.   

Abstract

The behavioral and clinical profiles of various benzodiazepines after acute and chronic treatment are not well defined and may differ. The aim of this study was to evaluate the behavioral profiles of alprazolam, bromazepam, diazepam and lorazepam in mice after single and repeated (every half-life for seven half-lives) administrations using a stimulation-sedation test (actimeter), a myorelaxation test (rotarod), and an anxiolysis test ("four plates"). A dose range from 0.03 to 4 mg/kg was used. A single administration of alprazolam showed stimulating and anxiolytic effects which diminished after repeated administration. Lorezapam's sedative effect diminished but its anxiolytic effect increased upon repeated administration. Except for lorazepam, the myorelaxing effect of all four drugs increased after repeated treatment. These results suggest that the behavioral profile of benzodiazepines may not be identical during acute and chronic treatment. These differences may be present in clinical treatment and warrant investigation in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637802      PMCID: PMC1188404     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  20 in total

1.  Low-dose alprazolam augments motor activity in mice.

Authors:  F Lopez; L G Miller; D J Greenblatt; S M Paul; R I Shader
Journal:  Pharmacol Biochem Behav       Date:  1988-06       Impact factor: 3.533

2.  Acute tolerance to diazepam induced by benzodiazepines.

Authors:  P T Wong; Y L Yoong; M C Gwee
Journal:  Clin Exp Pharmacol Physiol       Date:  1986-01       Impact factor: 2.557

3.  Tolerance to the benzodiazepine diazepam in an animal model of anxiolytic activity.

Authors:  D N Stephens; H H Schneider
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Evidence for a role for dopamine in the diazepam locomotor stimulating effect.

Authors:  B Söderpalm; L Svensson; P Hulthe; K Johannessen; J A Engel
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration.

Authors:  L G Miller; S Woolverton; D J Greenblatt; F Lopez; R B Roy; R I Shader
Journal:  Biochem Pharmacol       Date:  1989-11-01       Impact factor: 5.858

6.  Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance.

Authors:  S E File
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 7.  Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.

Authors:  G W Dawson; S G Jue; R N Brogden
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

8.  Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function.

Authors:  L G Miller; D J Greenblatt; R B Roy; W R Summer; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

9.  Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function.

Authors:  L G Miller; D J Greenblatt; J G Barnhill; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

10.  Withdrawal, tolerance and sensitization after a single dose of lorazepam.

Authors:  S E File; L J Wilks; P S Mabbutt
Journal:  Pharmacol Biochem Behav       Date:  1988-12       Impact factor: 3.533

View more
  13 in total

1.  Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests.

Authors:  Leanne M Fraser; Richard E Brown; Ahmed Hussin; Mara Fontana; Ashley Whittaker; Timothy P O'Leary; Lauren Lederle; Andrew Holmes; André Ramos
Journal:  Psychopharmacology (Berl)       Date:  2010-05-08       Impact factor: 4.530

2.  Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications.

Authors:  Robert H Ring; Jessica E Malberg; Lisa Potestio; Julia Ping; Steve Boikess; Bin Luo; Lee E Schechter; Stacey Rizzo; Zia Rahman; Sharon Rosenzweig-Lipson
Journal:  Psychopharmacology (Berl)       Date:  2006-01-18       Impact factor: 4.530

3.  Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test.

Authors:  Fabienne Massé; Martine Hascoët; Eric Dailly; Michel Bourin
Journal:  Psychopharmacology (Berl)       Date:  2005-11-24       Impact factor: 4.530

4.  Antianxiety-like activity of gallic acid in unstressed and stressed mice: possible involvement of nitriergic system.

Authors:  Dinesh Dhingra; Ritu Chhillar; Arun Gupta
Journal:  Neurochem Res       Date:  2011-10-28       Impact factor: 3.996

5.  Role of α1- and α2-GABA(A) receptors in mediating the respiratory changes associated with benzodiazepine sedation.

Authors:  S Masneuf; J Buetler; C Koester; F Crestani
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Diazepam Inhibits Post-Traumatic Neurogenesis and Blocks Aberrant Dendritic Development.

Authors:  Laura E Villasana; Austin Peters; Raluca McCallum; Chang Liu; Eric Schnell
Journal:  J Neurotrauma       Date:  2019-05-06       Impact factor: 5.269

7.  Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia.

Authors:  Kelvin W Gee; Minhtam B Tran; Derk J Hogenkamp; Timothy B Johnstone; Rudy E Bagnera; Ryan F Yoshimura; Jin-Cheng Huang; James D Belluzzi; Edward R Whittemore
Journal:  J Pharmacol Exp Ther       Date:  2009-11-25       Impact factor: 4.030

8.  Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice.

Authors:  Carolien van Rijnsoever; Marcus Täuber; Mohamed Khaled Choulli; Ruth Keist; Uwe Rudolph; Hanns Mohler; Jean Marc Fritschy; Florence Crestani
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

9.  TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.

Authors:  Jérôme Busserolles; Ismail Ben Soussia; Laetitia Pouchol; Nicolas Marie; Mathieu Meleine; Maïly Devilliers; Céline Judon; Julien Schopp; Loïc Clémenceau; Laura Poupon; Eric Chapuy; Serge Richard; Florence Noble; Florian Lesage; Sylvie Ducki; Alain Eschalier; Stéphane Lolignier
Journal:  Br J Pharmacol       Date:  2020-09-21       Impact factor: 8.739

10.  Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.

Authors:  Sarah K Leonard; Jason M Dwyer; Stacey J Sukoff Rizzo; Brian Platt; Sheree F Logue; Sarah J Neal; Jessica E Malberg; Chad E Beyer; Lee E Schechter; Sharon Rosenzweig-Lipson; Robert H Ring
Journal:  Psychopharmacology (Berl)       Date:  2008-03-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.